|MAKO Surgical Corp.|
2555 Davie Road
United States - Map
MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. In addition, the company offers MAKOplasty partial knee arthroplasty (PKA) products that enable resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to perform total hip arthroplasty. Further, it provides RESTORIS onlay knee implant system for patients who lack tibia sclerotic bone beds; RESTORIS MCK unicompartmental and bicompartmental knee implant system to support the tissue and bone sparing goals of MAKOplasty PKA; and RESTORIS family of hip implant systems. The company markets and sells its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida. As of December 17, 2013, MAKO Surgical Corp. operates as a subsidiary of Stryker Corporation.
|MAKO Surgical Corp.’s ISS Governance QuickScore as of Dec 1, 2013 is 7. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 9.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Fritz L. LaPorte CPA,
Chief Financial Officer and VP of Fin. & Admin.
|Mr. David K. Floyd ,
Principal Exec. Officer, Pres and Director
|Ms. Samantha Brodsky ,
Director of HR
|Mr. Robert C. Cohen ,
VP and Gen. Mang.
|Ms. Brandy Craig ,
Marketing Communications Mang.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|